2,2'-Disulfanediyldiacetic acid, diammonia salt

Catalog No. :
ACREHV562
CAS No. :
68223-93-8
Molecular Formula :
C4H12N2O4S2
Molecular Weight :
216.28

IUPAC Name:ammonium 2,2'-disulfanediyldiacetate

2,2'-Disulfanediyldiacetic acid, diammonia salt structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g97%$72.00Login to see priceInquiryInquiry
500g97%$236.00Login to see priceInquiryInquiry
1000g97%$399.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,2'-Disulfanediyldiacetic acid, diammonia salt
IUPAC Nameammonium 2,2'-disulfanediyldiacetate
MDL No.MFCD00072606
Molecular FormulaC4H12N2O4S2
Molecular Weight216.28
SMILESO=C([O-])CSSCC([O-])=O.[NH4+].[NH4+]
InChI KeyRZOXALOSBVDYRY-UHFFFAOYSA-N
SynonymDithiodiacetic Acid Diammonium Salt | AKOS028109660 | Dithiodiglycolic Acid Diammonium Salt | EC 269-323-4 | Diammonium Dithiodiacetate | Diammonium dithiodiglycolate | diazanium;2-(carboxylatomethyldisulfanyl)acetate | Diammonium 2,2'-dithiodiacetate | E
CAS No.68223-93-8
PubChem CID6455809

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACREHV562 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPTFB326 route compound structure diagram
    ACPTFB3261068-52-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACREHV562 route product structure diagram
    ACREHV56268223-93-8
Inquiry

2. ACREHV562 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACREHV562 route product structure diagram
    ACREHV56268223-93-8
Inquiry

Comments (0)